Erratum (DOI:10.1016/j.jacl.2009.02.006);Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity

Journal of Clinical Lipidology

Volumn 3, Issue 2, 2009, Pages 78-84

  Su, Jenny W ^a   Ugo Nzekwu, Mary Magdelena ^a   Ball, Geoff D C ^a   Proctor, Spencer D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apo B48; Cardiovascular disease; Chylomicrons; Insulin resistance; Obesity; Pediatrics

Indexed keywords

CHOLESTEROL; CHYLOMICRON;

CARDIOVASCULAR DISEASE; CHILDHOOD; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; DRUG TARGETING; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; HYPOTHESIS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; VASCULAR DISEASE;

EID: 61949389164     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.11.001     Document Type: Erratum

References (69)

1. Lobstein T., Baur L., and Uauy R. Obesity in children and young people: a crisis in public health. Obes Rev. 5 suppl 1 (2004) 4-85
2. Rosenbloom A.L., Joe J.R., Young R.S., and Winter W.E. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22 (1999) 345-354
3. McCrindle B.W., and Malhoit C. Elevated atherogenic lipoproteins in childhood: risk, prevention, and treatment. J Clin Lipidol 2 (2008) 138-146
4. McMahan C.A., Gidding S.S., and McGill H.C. Coronary heart disease risk factors and atherosclerosis in young people. J Clin Lipidol 2 (2008) 118-126
5. Mietus-Synder M., and Krauss R.M. Lipid metabolism in children and adolescents: impact on vascular biology. J Clin Lipidol 2 (2008) 127-137
6. Higashi K., Ito T., Nakajima K., et al. Remnant-like particle cholesterol is higher in diabetic patients with coronary artery disease. Metabolism 50 (2001) 1462-1465
7. Tomkin G.H., and Owens D. Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis. Diabetes Metab Res Rev. 17 (2001) 27-43
8. Schaefer E.J., McNamara J.R., Shah P.K., et al. Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study. Diabetes Care 23 (2002) 1766-1769
9. Proctor S.D., Vine D.F., and Mamo J.C. Arterial retention of apolipoprotein B48 and B100-containing lipoproteins in atherogenesis. Curr Opin Lipidol 13 (2002) 110-118
10. Huff M.W. Dietary cholesterol, cholesterol absorption, post-prandial lipemia and atherosclerosis. Can J Clin Pharmacol 10 Suppl A (2003) 26A-32A
11. Twickler T., Dallinga-Thie G.M., Chapman M.J., and Cohn J.S. Remnant lipoproteins and atherosclerosis. Curr Atheroscler Rep 7 (2005) 140-147
12. Mamo J.C., and Wheeler J.R. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin. Coronary Art Dis 5 (1994) 695-705
13. Proctor S.D., Pabla C.K., and Mamo J.C. Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats. Atherosclerosis 149 (2000) 315-322
14. Coppack S.W. Post-prandial lipoproteins in non-insulin-dependent diabetes mellitus. Diabetic Med 14 (1997) S67-S74
15. Malmström R., Packard C.J., Caslake M., et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40 (1997) 454-462
16. Duez H., Lamarche B., Uffelman K.D., Valero R., Cohn J.S., and Lewis G.F. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 26 (2006) 1357-1363
17. Hogue J., Lamarache B., Tramblay A.J., Bergeron J., Gagné C., and Couture P. Evidence of increased secretion of apolipoprotein B48-containing lipoproteins in subjects with type 2 diabetes. J Lipid Res. 48 (2007) 1336-1342
18. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Glegal K.M. Prevalence of overweight and obesity among US children, adolescents and adults. JAMA 291 (2004) 2847-2850
19. Tjepkema M., and Shields M. Measured obesity: overweight Canadian children and adolescents. Nutrition Findings from the Canadian Community Health Survey. Health Report 17 (2006) 27-42
20. Lauer R.M., Lee J., and Clarke W.R. Factors affecting the relationship between childhood and adult cholesterol levels. The Muscatine Study. Pediatrics 182 (1988) 309-318
21. Freedman D.S., Khan L.K., Dietz W.H., Srinivasan S.R., and Berenson G.S. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The Bogalusa Heart Study. Pediatrics 108 (2001) 712-718
22. Maffeis C., Moghetti P., Grezzani A., Clementi M., Gaudino R., and Tatò L. Insulin resistance and the persistence of obesity from childhood into adulthood. J Clin Endocrinol Metab 87 (2002) 71-76
23. Ferraro K.F., Thorpe Jr. R.J., and Wilkinson J.A. The life course of severe obesity: does childhood overweight matter?. J Gerontol Series B-Psychol Sci Social Sci. 58 (2003) S110-S119
24. Raitakari O.T., Juonala M., and Viikari J.S.A. Obesity in childhood and vascular changes in adulthood: insights into the Cardiovascular Risk in Young Finns Study. Int J Obes 29 (2005) S101-S104
25. Arslanian S., and Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present?. J Clin Endocrinol Metab. 81 (1996) 1058-1062
26. Kohen-Avramoglu R., Theriault A., and Adeli K. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem 36 (2003) 413-420
27. Weiss R., Taksali S.E., Tamborlane W.V., Burgert T.S., Savoye M., and Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28 (2005) 902-909
28. Epstein L.H., Valoski A., Wing R.R., and McCurley J. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol 13 (1994) 373-383
29. Webber L.S., Osganian S.K., Feldman H.A., et al. Cardiovascular risk factors among children after a 2 1/2-year intervention-the CATCH Study. Prev Med 25 (1996) 432-441
30. Robinson T.N. Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA 282 (1999) 1561-1567
31. Shrewsbury V., and Wardle J. Socioeconomic status and adiposity in childhood: a systematic review of cross-sectional studies 1990-2005. Obesity 16 (2008) 275-284
32. Killeen J., Vanderburg D., and Harlan W.R. Application of weight-height ratios and body indices to juvenile populations: the National Health Examination Survey data. J Chronic Dis 31 (1978) 529-537
33. Frerichs R.R., Webber L.S., Srinivasan S.R., and Berenson G.S. Relation of serum lipids and lipoproteins to obesity and sexual maturity in white and black children. Am J Epidemiol 108 (1978) 486-496
34. Laskarzewski P., Morrison J.A., Mellies M.J., et al. Relationships of measurements of body mass to plasma lipoprotein in school children and adults. Am J Epidemiol 111 (1980) 395-406
35. Resnicow K., and Morabia A. The relation between body mass index and plasma total cholesterol in a multiracial sample of US schoolchildren. Am J Lipidemiol 132 (1990) 1083-1089
36. Williams D.P., Going S.B., Lohman T.G., et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolscents. Am J Public Health 82 (1992) 358-363
37. Freedman D.S., Dietz W.H., Srinivasan S.R., and Berenson G.S. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 103 (1999) 1175-1182
38. Reinehr T., Andler W., Denzer C., Siegried W., Hayer H., and Wabitsch M. Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis 15 (2005) 181-187
39. Morrison J.A., James F.W., Sprecher D.L., Khoury P.R., and Daniels S.R. Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975-1990: The Princeton School Study. Am J Public Health 89 (1999) 1708-1714
40. Manios Y., Magkos F., Christakis G., and Kafatos A.G. Changing relationships of obesity and dyslipidemia in Greek children: 1982-2002. Prev Med 41 (2005) 846-851
41. Burke V., Beilin L.J., Simmer K., et al. Predictors of body mass index and associations with cardiovascular risk factors in Australian children. Int J Obes 29 (2005) 15-23
42. Srinivasan S.R., Bao W., Wattingney W.A., and Berenson G.S. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: The Bogalusa Heart Study. Metabolism 45 (1996) 235-240
43. Nicklas T.A., von Duvillard S.P., and Berenson G.S. Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Int J Sports Med 23 suppl 1 (2002) S39-S43
44. Srinivasan S.R., Frontini M.G., Xu J., and Berenson G.S. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: The Bogalusa Heart Study. Pediatrics 118 (2006) 201-206
45. Baker J.L., Olsen L.W., and Sorensen T.I.A. Childhood body mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357 (2007) 2329-2337
46. DiPietro L., Mossberg H., and Stunkard A.J. A 40-year history of overweight children in Stockholm: life-time overweight, morbidity and mortality. Int J Obes 18 (1994) 585-590
47. Falkstedt D., Hemmingsson T., Rasmussen F., and Lundbert I. Body mass index in late adolescence and its association with coronary heart disease and stroke in middle age among Swedish men. Int J Obes 31 (2007) 777-783
48. Gunnell D.J., Frankel S.J., Nanchahal K., et al. Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr 67 (1998) 1111-1118
49. Must A., Jacques P.F., Dallal G.E., Bajema C.J., and Dietz W.H. Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 327 (1992) 1350-1355
50. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., and Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007) 309-316
51. Børge G., Nordestgaard B.G., Benn M., Schnohr P., and Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298 (2007) 299-308
52. Chan D.C., Watts G.F., Barrett P.H., Mamo J.C., and Redgrave T.G. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clin Chem. 48 (2002) 278-283
53. Redgrave T.G. Chylomicron metabolism. Biochem Soc Trans. 32 (2004) 79-82
54. Duez H., Pavlic M., and Lewis G.F. Mechanism of intestinal lipoprotein overproduction in insulin resistant humans. Atherosclerosis 9 (2008) 33-38
55. Hsieh J., Hayashi A., Webb J., and Adeli K. Post-prandial dyslipidemia in insulin resistance: Mechanisms and role of intestinal insulin sensitivity. Atherosclerosis 9 (2008) 7-13
56. Vine D.F., Glimm D.R., and Proctor S.D. Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome. Athero. Suppl 9 (2008) 69-76
57. Alipour A., Elte J.W., van Zaanen H.C., Rietveld A.P., and Cabezas M.C. Novel aspects of post-prandial lipemia in relation to atherosclerosis. Athero. Suppl 9 (2008) 39-44
58. Weintraub M.S., Grosskopf I., Rassin T., et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 312 (1996) 936-939
59. Rajaratnam R.A., Gylling H., and Miettinen T.A. Impaired post-prandial clearance of squalene and apolipoprotein B-48 in post-menopausal women with coronary artery disease. Clin Sci. 97 (1999) 183-192
60. Mero N., Malmström R., Steiner G., Taskinen M.R., and Syvänne M. Post-prandial metabolism of apolipoprotein B-48 and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 150 (2000) 167-177
61. McNamara J.R., Shah P.K., Nakajima K., Cupples L.A., Wilson P.W.F., and Ordovas J.M. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham heart study. Atherosclerosis 154 (2001) 229-236
62. Imke C., Rodriguez B.L., Grove J.S., et al. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart Study. Arterioscler Thromb Vasc Biol. 25 (2005) 1718-1722
63. Smith D., Watts G.F., Dane-Stewart C., and Mamo J.C. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state. Eur J Clin 29 (1999) 204-209 Invest
64. Dane-Stewart C.A., Watts G.F., Barrett P.H., et al. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus. Clin Endocrinol 58 (2003) 415-420
65. Chan D.C., Watts G.F., Barrett P.H., et al. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test. J Lipid Res. 43 (2002) 706-712
66. Mamo J.C., Watts G.F., Barrett P.H., Smith D., James A.P., and Pal S. Post-prandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?. Am J Physiol Endocrinol Metab 281 (2001) E626-E632
67. Redgrave T.G., Watts G.F., Martins I.J., Barrett P.H.R., Mamo J.C.L., Dimmitt S.B., and Ma A.D. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test. J Lipid Res. 42 (2001) 710-715
68. Nzekwu M.M.U., Ball G.D.C., Jetha M.M., Beaulieu C., and Proctor S.D. Apolipoprotein B48: a novel marker of metabolic risk in overweight children?. Biochem Soc Trans. 25 (2007) 484-486
69. Humphries M.C., Gutin B., Barbeau P., Vemulapalli S., Allison J., and Owens S. Relations of adiposity and effects of training on the left ventricle in obese youths. Med Sci Sports Exercise 34 (2002) 1428-1435